{"id":388066,"date":"2025-11-18T17:50:17","date_gmt":"2025-11-18T17:50:17","guid":{"rendered":"https:\/\/www.europesays.com\/us\/388066\/"},"modified":"2025-11-18T17:50:17","modified_gmt":"2025-11-18T17:50:17","slug":"government-issues-statement-on-weight-loss-jab-mounjaro-after-nhs-eligibility-concerns","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/388066\/","title":{"rendered":"Government issues statement on weight loss jab Mounjaro after ‘NHS eligibility’ concerns"},"content":{"rendered":"

The NHS is rolling out Mounjaro with a focus on those with the “highest clinical need”\"AMore than a million people in the UK are estimated to be currently using weight loss jabs(Image: PA)<\/p>\n

The Government has issued a response after concerns that some patients with weight-related health problems won’t be able to access the new weight loss jab Mounjaro on the NHS<\/a>.<\/p>\n

Tirzepatide – better known as Mounjaro – is a weight loss medicine that makes patients feel fuller for longer<\/a> and therefore less hungry. It comes in the form of an injection, which is self-administered once a week.<\/p>\n

The jab was approved for use in England in 2023 and was initially only available through specialist weight-loss services.<\/p>\n

In June, thousands more patients became eligible to get the drug through their GP in an NHS rollout<\/a>. Currently, patients with a BMI of 40 or higher and multiple obesity-related health problems are eligible.<\/p>\n

Labour<\/a> MP Mohammad Yasin, who represents Bedford, pressed the Department of Health and Social Care on what support is available for people living with multiple obesity-related conditions but who don\u2019t currently meet the NHS threshold for Mounjaro.<\/p>\n

Responding on Tuesday (November 18), Health Minister Ashley Dalton said the National Institute for Health and Care Excellence (NICE), which decides whether new medicines are clinically and cost-effective, has estimated around 3.4 million people will be eligible for the jab under its guidance.<\/p>\n

\"AshleyAshley Dalton MP is the Parliamentary Under-Secretary of State for Public Health and Prevention(Image: PA)<\/p>\n

The NHS is rolling out the jab with a focus on those with the “highest clinical need”, Ms Dalton said. Health bosses say that around 220,000 people are expected to receive Mounjaro<\/a> through the NHS over the next three years.<\/p>\n

In the mass roll out, the drug will be given to certain people with a BMI over 40, or 37.5 in patients from a minority ethnic background. These patients must have at least four out of five of the following health problems linked to obesity:<\/p>\n